These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 21901862)

  • 1. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
    Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S
    Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
    Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial T-SPOT.TB and quantiFERON-TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection.
    Chiappini E; Bonsignori F; Mangone G; Galli L; Mazzantini R; Sollai S; Azzari C; de Martino M
    Pediatr Infect Dis J; 2012 Sep; 31(9):974-7. PubMed ID: 22572749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snapshot of Quantiferon TB gold testing in Northern Mexico.
    González-Salazar F; Vargas-Villarreal J; Garcialuna-Martínez FJ; Rivera G; Moreno-Treviño MG; Montfort-Gardeazabal JM; Garcialuna-Martínez E
    Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S34-7. PubMed ID: 22099419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].
    Knappik M; Schönfeld N; Günther A; Bergmann T; Magdorf K; Rüssmann H; Mauch H; Barker M
    Pneumologie; 2012 Apr; 66(4):207-11. PubMed ID: 22477480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
    Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
    Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents.
    Bergamini BM; Losi M; Vaienti F; D'Amico R; Meccugni B; Meacci M; De Giovanni D; Rumpianesi F; Fabbri LM; Balli F; Richeldi L
    Pediatrics; 2009 Mar; 123(3):e419-24. PubMed ID: 19254978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma mRNA quantitative real-time polymerase chain reaction for the diagnosis of latent tuberculosis: a novel interferon gamma release assay.
    Kim S; Kim YK; Lee H; Cho JE; Kim HY; Uh Y; Kim YM; Kim H; Cho SN; Jeon BY; Lee H
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):68-72. PubMed ID: 23102550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of latent tuberculosis infection in rural Jiangsu, China.
    Liu Y; Huang S; Jiang H; Xiong J; Wang Y; Ou M; Cai J; Yang C; Wang Z; Ge S; Xia N
    Public Health; 2017 May; 146():39-45. PubMed ID: 28404472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
    Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
    Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
    Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
    J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.